Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study

BACKGROUND: The aim of this study was to assess the efficacy and safety of amrubicin for previously treated malignant pleural mesothelioma. METHODS: The eligibility criteria were: previously treated unresectable malignant pleural mesothelioma; performance status 0–1; age ≤ 75; adequate hematological...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Takaya, Takemoto, Shinnosuke, Senju, Hiroaki, Gyotoku, Hiroshi, Taniguchi, Hirokazu, Shimada, Midori, Dotsu, Yosuke, Umeyama, Yasuhiro, Tomono, Hiromi, Kitazaki, Takeshi, Fukuda, Masaaki, Soda, Hiroshi, Yamaguchi, Hiroyuki, Fukuda, Minoru, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327919/
https://www.ncbi.nlm.nih.gov/pubmed/32462731
http://dx.doi.org/10.1111/1759-7714.13490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327919/
https://www.ncbi.nlm.nih.gov/pubmed/32462731
http://dx.doi.org/10.1111/1759-7714.13490

Ejemplares similares